Arix Assembles New Teams To Advance Portfolio
Establishes Scientific Advisory Board And An Investment Committee
Executive Summary
Arix Biosciences has unveiled three significant changes to the organization, including the appointment of Christian Schetter as co-managing director, which the healthcare-focused venture capitalist hopes will keep its impressive record of biotech investments on track.